Kestra Private Wealth Services
ABBV icon

Kestra Private Wealth Services’s AbbVie ABBV Stock Holding History

Kestra Private Wealth Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$45.4M Sell
173,709
-6,916
-4% -$1.77M 0.48% 34
2026
Q2 		$45.5M Buy
180,625
+3,439
+2% +$740K 0.5% 30
2026
Q1 		$38.5M Buy
177,186
+5,266
+3% +$1.17M 0.48% 36
2025
Q4 		$39.3M Buy
171,920
+829
+0.5% +$189K 0.49% 33
2025
Q3 		$39.6M Buy
171,091
+7,387
+5% +$1.5M 0.52% 30
2025
Q2 		$30.4M Buy
163,704
+10,179
+7% +$1.89M 0.44% 39
2025
Q1 		$32.2M Buy
153,525
+5,423
+4% +$1.05M 0.54% 35
2024
Q4 		$26.3M Buy
148,102
+8,835
+6% +$1.62M 0.45% 38
2024
Q3 		$27.5M Buy
139,267
+861
+0.6% +$161K 0.5% 35
2024
Q2 		$23.7M Buy
138,406
+21,793
+19% +$3.61M 0.48% 38
2024
Q1 		$21.2M Buy
116,613
+307
+0.3% +$52.9K 0.48% 40
2023
Q4 		$18M Buy
116,306
+7,289
+7% +$1.06M 0.46% 42
2023
Q3 		$16.3M Buy
109,017
+9,011
+9% +$1.32M 0.51% 40
2023
Q2 		$13.5M Buy
100,006
+1,371
+1% +$201K 0.46% 45
2023
Q1 		$15.7M Buy
98,635
+8,021
+9% +$1.23M 0.63% 26
2022
Q4 		$14.6M Buy
90,614
+368
+0.4% +$56.4K 0.74% 20
2022
Q3 		$12.1M Buy
90,246
+2,026
+2% +$291K 0.7% 19
2022
Q2 		$13.5M Sell
88,220
-6,812
-7% -$1.04M 0.77% 15
2022
Q1 		$15.4M Buy
95,032
+4,194
+5% +$609K 0.76% 16
2021
Q4 		$12.3M Buy
90,838
+2,247
+3% +$265K 0.59% 25
2021
Q3 		$9.6M Buy
88,591
+24,508
+38% +$2.8M 0.53% 30
2021
Q2 		$7.22M Buy
64,083
+5,986
+10% +$674K 0.44% 40
2021
Q1 		$6.29M Buy
58,097
+2,180
+4% +$233K 0.44% 51
2020
Q4 		$5.89M Sell
55,917
-830
-1% -$79.8K 0.43% 49
2020
Q3 		$4.98M Buy
+56,747
New +$5.34M 0.43% 54

Other funds holding ABBV

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Kestra Private Wealth Services's ABBV Position: Q3 2026 in Review

Kestra Private Wealth Services reduced its AbbVie (ABBV) stake by 3.8% in Q3 2026, selling an estimated $1.77M and leaving 173,709 shares worth $45.4M. The position accounts for 0.48% of the portfolio, ranked #34.

Kestra Private Wealth Services first reported a position in ABBV in Q3 2020 and has held it in 25 quarters since. The position peaked at $45.5M in Q2 2026. 3,176 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Kestra Private Wealth Services held 173,709 shares of AbbVie worth $45.4M as of Q3 2026.
  • Kestra Private Wealth Services sold 6,916 AbbVie shares in Q3 2026, an estimated $1.77M.
  • AbbVie made up 0.48% of Kestra Private Wealth Services's portfolio in Q3 2026, its #34 holding.
  • Kestra Private Wealth Services first reported a position in AbbVie in Q3 2020 and has held it in 25 quarters since.
  • Kestra Private Wealth Services's AbbVie position peaked at $45.5M in Q2 2026.
  • 3,176 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Kestra Private Wealth Services's 13F filing for Q3 2026, filed 30 Oct 2026.